Has James Sligh received payments from drug or device companies?

Yes. Drug and device makers reported $237,900 in general payments to James Sligh across 214 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean James Sligh did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about James Sligh come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

James Sligh

Dermatology · Tucson, AZNPI 1366539462

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $181,538 of the $237,900 with a category attached, or 76.3%. Genentech USA, Inc. accounts for 93.8% of it on its own, with 13 other manufacturers making up the rest. Among dermatology clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$237,900in general payments, 2019–2025

Across 214 payments — averaging $1111.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Genentech USA, Inc.$223K
Regeneron Healthcare Solutions, Inc.$10K
Sanofi$4K
Biofrontera Inc.$122
Novartis$109
Johnson & Johnson$85
plus $274 from 8 others

$50,120in research payments, 2019–2025

Across 12 payments — averaging $4176.65 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

LEO Pharma AS$48K
Hoffmann-la Roche Limited$3K

What the payments were for

Consulting fees$9,3204%
Speaking & faculty fees$181,53876%
Travel & lodging$41,88718%
Food & beverage$5,0832%
Education$720%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Genentech USA, Inc.	159	$223,197
Regeneron Healthcare Solutions, Inc.	16	$9,769
Sanofi	15	$4,345
Biofrontera Inc.	2	$122
Novartis	6	$109
Johnson & Johnson	2	$85
Sun Pharmaceutical Industries Inc.	1	$70
AbbVie	4	$68
Musculoskeletal Transplant Foundation Inc.	3	$45
Ortho Dermatologics, A Division Of Bausch Health US, LLC	1	$30
Prugen, Inc. Pharmaceuticals	2	$19
LEO Pharma Inc.	1	$16
Lilly USA, LLC	1	$13
Organogenesis Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Erivedge$221,702
LIBTAYO$12,336
AMELUZ$102
BF-RhodoLED$102
XEPI$102

How this compares

$237,900 in reported general payments places this provider in the 95th percentile of 305 dermatology providers in Arizona.

See all dermatology providers in Arizona →

Other dermatology in Tucson

Kathleen ObrienTucson$742K
Clara CurielTucson$20K
Elka EisenTucson$15K
Scott SheftelTucson$11K
Matthew BealTucson$9K
Robyn GlaesserTucson$9K
Lindsay AckermanPhoenix$1.6M
Nathalie ZeitouniPhoenix$584K
John KastelerGilbert$456K
Anthony NuaraScottsdale$432K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →